Unknown OBSERVATIONAL NCT00959023

Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer

UK Genetic Prostate Cancer Study

Sponsor: Institute of Cancer Research, United Kingdom

Interventions laboratory biomarker analysis medical chart review questionnaire administration

Updated 7 times since 2017 Last updated: Aug 23, 2013 Started: Jun 30, 1993

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Prostate Cancer, this trial is ongoing. The trial is conducted by Institute of Cancer Research, United Kingdom and has accumulated 7 data snapshots since 1993. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Jun 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institute of Cancer Research, United Kingdom

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aberdeen, United Kingdom , Ashford-Kent, United Kingdom , Ashton-under-Lyne, United Kingdom , Aylesbury-Buckinghamshire, United Kingdom , Ayr, United Kingdom , Barnstaple, United Kingdom , Barrow in Furness, United Kingdom , Basildon, United Kingdom , Basingstoke, United Kingdom , Bath, United Kingdom and 105 more locations